Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,062 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region.
Chan DD, Chang LY, Akesson KE, Mitchell P, Chen CH, Lewiecki EM, Lee JK, Lau TC, Songpatanasilp T, Lee KB, Kim KJ, Chen JF, Huang KE, Gau YL, Chang YF, Ebeling P, Xia W, Yu W, Suzuki A, Hew FL, Mercado-Asis LB, Chung YS, Tsai KS, Lin GT, Yang RS, Wu CH. Chan DD, et al. Among authors: xia w. Arch Osteoporos. 2018 Jul 3;13(1):73. doi: 10.1007/s11657-018-0485-x. Arch Osteoporos. 2018. PMID: 29971507
Consensus on best practice standards for Fracture Liaison Service in the Asia-Pacific region.
Chan DD, Chang LY, Akesson KE, Mitchell P, Chen CH, Lewiecki EM, Lee JK, Lau TC, Songpatanasilp T, Lee KB, Kim KJ, Chen JF, Huang KE, Gau YL, Chang YF, Ebeling P, Xia W, Yu W, Suzuki A, Hew FL, Mercado-Asis LB, Chung YS, Tsai KS, Lin GT, Yang RS, Wu CH. Chan DD, et al. Among authors: xia w. Arch Osteoporos. 2018 May 12;13(1):59. doi: 10.1007/s11657-018-0463-3. Arch Osteoporos. 2018. PMID: 29754189 Review.
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific Region.
Wu CH, Chang YF, Chen CH, Lewiecki EM, Wüster C, Reid I, Tsai KS, Matsumoto T, Mercado-Asis LB, Chan DC, Hwang JS, Cheung CL, Saag K, Lee JK, Tu ST, Xia W, Yu W, Chung YS, Ebeling P, Mithal A, Ferrari SL, Cooper C, Lin GT, Yang RS. Wu CH, et al. Among authors: xia w. J Clin Densitom. 2021 Jan-Mar;24(1):3-13. doi: 10.1016/j.jocd.2019.03.004. Epub 2019 Mar 20. J Clin Densitom. 2021. PMID: 31010789 Free article.
Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
McClung MR, O'Donoghue ML, Papapoulos SE, Bone H, Langdahl B, Saag KG, Reid IR, Kiel DP, Cavallari I, Bonaca MP, Wiviott SD, de Villiers T, Ling X, Lippuner K, Nakamura T, Reginster JY, Rodriguez-Portales JA, Roux C, Zanchetta J, Zerbini CAF, Park JG, Im K, Cange A, Grip LT, Heyden N, DaSilva C, Cohn D, Massaad R, Scott BB, Verbruggen N, Gurner D, Miller DL, Blair ML, Polis AB, Stoch SA, Santora A, Lombardi A, Leung AT, Kaufman KD, Sabatine MS; LOFT Investigators. McClung MR, et al. Lancet Diabetes Endocrinol. 2019 Dec;7(12):899-911. doi: 10.1016/S2213-8587(19)30346-8. Epub 2019 Oct 31. Lancet Diabetes Endocrinol. 2019. PMID: 31676222 Clinical Trial.
5,062 results